- Home
- EHLD vs EDSA Comparison
EHLD vs EDSA Comparison
Compare EHLD & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHLD
- EDSA
- Stock Information
- Founded
- EHLD 2024
- EDSA 2015
- Country
- EHLD Greece
- EDSA Canada
- Employees
- EHLD N/A
- EDSA N/A
- Industry
- EHLD
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- EHLD
- EDSA Health Care
- Exchange
- EHLD NYSE
- EDSA Nasdaq
- Market Cap
- EHLD 17.2M
- EDSA 14.7M
- IPO Year
- EHLD N/A
- EDSA N/A
- Fundamental
- Price
- EHLD $7.82
- EDSA $2.38
- Analyst Decision
- EHLD
- EDSA Strong Buy
- Analyst Count
- EHLD 0
- EDSA 2
- Target Price
- EHLD N/A
- EDSA $13.00
- AVG Volume (30 Days)
- EHLD 14.9K
- EDSA 33.6K
- Earning Date
- EHLD 08-15-2025
- EDSA 08-08-2025
- Dividend Yield
- EHLD 7.16%
- EDSA N/A
- EPS Growth
- EHLD N/A
- EDSA N/A
- EPS
- EHLD 4.74
- EDSA N/A
- Revenue
- EHLD $14,687,504.00
- EDSA N/A
- Revenue This Year
- EHLD N/A
- EDSA N/A
- Revenue Next Year
- EHLD N/A
- EDSA N/A
- P/E Ratio
- EHLD $1.65
- EDSA N/A
- Revenue Growth
- EHLD N/A
- EDSA N/A
- 52 Week Low
- EHLD $3.83
- EDSA $1.55
- 52 Week High
- EHLD $12.80
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- EHLD N/A
- EDSA 66.47
- Support Level
- EHLD N/A
- EDSA $2.31
- Resistance Level
- EHLD N/A
- EDSA $2.52
- Average True Range (ATR)
- EHLD 0.00
- EDSA 0.14
- MACD
- EHLD 0.00
- EDSA 0.02
- Stochastic Oscillator
- EHLD 0.00
- EDSA 74.24
About EHLD EUROHOLDINGS LTD
Euroholdings Ltd is a provider of shipping transportation services. The company specializes in the ownership of vessels. The fleet of the company consists of containerships that transport container boxes providing scheduled service between ports.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.